ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,051,000 | +95.4% | 11,310 | +25.2% | 0.01% | +66.7% |
| Q3 2021 | $538,000 | +6.3% | 9,030 | +21.8% | 0.00% | 0.0% |
| Q2 2021 | $506,000 | +16.1% | 7,416 | +18.1% | 0.00% | +50.0% |
| Q1 2021 | $436,000 | +10.9% | 6,278 | +22.9% | 0.00% | 0.0% |
| Q4 2020 | $393,000 | +65.1% | 5,109 | +60.6% | 0.00% | 0.0% |
| Q3 2020 | $238,000 | -10.5% | 3,182 | -45.0% | 0.00% | 0.0% |
| Q3 2018 | $266,000 | -37.0% | 5,790 | -40.2% | 0.00% | -33.3% |
| Q2 2018 | $422,000 | +23.0% | 9,685 | +11.5% | 0.00% | +50.0% |
| Q1 2018 | $343,000 | -22.9% | 8,685 | -33.6% | 0.00% | -33.3% |
| Q4 2017 | $445,000 | – | 13,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |